Public-health officials may not have to worry so much about the low percentage of girls who don’t get all three doses of the …
The human papillomavirus (HPV) vaccine, approved in 2006, protects against strains of the virus responsible for 70% of cervical cancers. But what about the remaining 30%?
Concerns over an immunization aimed at a sexually transmitted virus may be unfounded
Confused about when or what cervical cancer screen you should get? A new study finds that HPV testing may benefit women over 30.
An intriguing new study finds a link between human papillomavirus, or HPV, the common sexually transmitted infection that is the cause of most cervical cancer, and an increased risk of heart attack and stroke in women.
The number of head and neck cancers linked to the sexually transmitted human papillomavirus (HPV) has increased sharply over the past two decades, and the virus now accounts for more cancers than tobacco or alcohol, a new study finds.